Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

HALEOS LABS LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE1169.0050.6 (+4.52 %)

PREV CLOSE ( ) 1118.40

OPEN PRICE ( ) 1118.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 143

TODAY'S LOW / HIGH ( )1118.40 1169.00

52 WK LOW / HIGH ( )956.05 1747.85

NSE1165.0053.6 (+4.82 %)

PREV CLOSE( ) 1111.40

OPEN PRICE ( ) 1100.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1165.00 (14)

VOLUME 1416

TODAY'S LOW / HIGH( ) 1100.00 1178.00

52 WK LOW / HIGH ( )959.8 1749.65

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-05 2006

Management Info

- Chairman TVVSN Murthy - Managing Director

Registered Office

Address Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040-66288888

Email info@smslife.in

Website www.smslife.in

Registrars Details

Aarthi Consultants Pvt Ltd

1-2-285 ,Domalaguda,,Hyderabad

Listing : BSE, NSE

NEWS

16Jul SMS Lifesciences India receives EIR wi
SMS Lifesciences India has received establishment inspection report (EIR..

16Jul SMS Lifesciences India informs about r
In continuation to its earlier communication dated May 9, 2025 regarding..

16Jul SMS Lifesciences India trades jubilant
SMS Lifesciences is currently trading at Rs. 1275.15, up by 131.35 point..

09May USFDA completes inspection at SMS Life
United States Food and Drug Administration (USFDA) has completed inspect..

05Apr SMS Lifesciences India informs about d
SMS Lifesciences India has confirmed that the following persons whose re..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	51.5899999999999	213.7
Gross Profit	74.7899999999999	300.4
Operating Profit	118.46	481.77
Net Sales	790.43	3333.71

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE) 1011.20 (9.54%)	M.Cap ( in Cr)38685.19
Procter&Gamble Healt (BSE) 6525.95 (0.94%)	M.Cap ( in Cr)10832.67
Glaxosmithkline Phar (BSE) 2811.40 (1.48%)	M.Cap ( in Cr)47626.81
Caplin Point Lab (BSE) 2174.00 (1.76%)	M.Cap ( in Cr)16524.94
Fredun Pharma (BSE) 1325.30 (2.35%)	M.Cap ( in Cr)625.76

Shareholding Pattern

	PROMOTERS	71.41%
	NON-INSTITUTION	28.56%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

HALEOS LABS LTD.